» Articles » PMID: 30686041

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and The...

Citing Articles

A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese.

Yang Z, Li Q, Yu D, Zhang X, Wang Y, Liu S BMC Pharmacol Toxicol. 2025; 26(1):62.

PMID: 40087806 DOI: 10.1186/s40360-025-00896-1.


Design and Evaluation of ACAFiB-APP, a clinical decision support system for anticoagulant considerations in patients with atrial fibrillation.

Ansari R, Rezayi S, Safaei A, Mollazadeh R, Rezaei E, Mafinejad M BMC Cardiovasc Disord. 2025; 25(1):166.

PMID: 40057691 PMC: 11889798. DOI: 10.1186/s12872-025-04615-w.


Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation.

Li X, Xiao Z, Zhang J, Huang X, Lin H, Huang S BMC Cardiovasc Disord. 2025; 25(1):163.

PMID: 40055600 PMC: 11887063. DOI: 10.1186/s12872-025-04597-9.


Perioperative atrial fibrillation.

Haysley J, Soliman-Aboumarie H, Huang J, Kalra D BJA Educ. 2025; 25(3):99-106.

PMID: 40034815 PMC: 11872467. DOI: 10.1016/j.bjae.2024.10.006.


Pulmonary Infarction Due to Direct-acting Oral Anticoagulant Malabsorption.

Rajashekar N, Mostaghimi D, Jiang F, Sanchez A J Brown Hosp Med. 2025; 3(1):90274.

PMID: 40027385 PMC: 11864386. DOI: 10.56305/001c.90274.